248 related articles for article (PubMed ID: 12808096)
1. Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation.
Coulombe P; Rodier G; Pelletier S; Pellerin J; Meloche S
Mol Cell Biol; 2003 Jul; 23(13):4542-58. PubMed ID: 12808096
[TBL] [Abstract][Full Text] [Related]
2. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.
Coulombe P; Rodier G; Bonneil E; Thibault P; Meloche S
Mol Cell Biol; 2004 Jul; 24(14):6140-50. PubMed ID: 15226418
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity.
Mathien S; Déléris P; Soulez M; Voisin L; Meloche S
Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28167606
[TBL] [Abstract][Full Text] [Related]
4. The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology.
Brand F; Schumacher S; Kant S; Menon MB; Simon R; Turgeon B; Britsch S; Meloche S; Gaestel M; Kotlyarov A
Mol Cell Biol; 2012 Jul; 32(13):2467-78. PubMed ID: 22508986
[TBL] [Abstract][Full Text] [Related]
5. Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.
Seternes OM; Mikalsen T; Johansen B; Michaelsen E; Armstrong CG; Morrice NA; Turgeon B; Meloche S; Moens U; Keyse SM
EMBO J; 2004 Dec; 23(24):4780-91. PubMed ID: 15577943
[TBL] [Abstract][Full Text] [Related]
6. C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis.
Tanguay PL; Rodier G; Meloche S
Biochem J; 2010 Apr; 428(1):103-11. PubMed ID: 20236090
[TBL] [Abstract][Full Text] [Related]
7. Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway.
Déléris P; Trost M; Topisirovic I; Tanguay PL; Borden KL; Thibault P; Meloche S
J Biol Chem; 2011 Feb; 286(8):6470-8. PubMed ID: 21177870
[TBL] [Abstract][Full Text] [Related]
8. Different domains of the mitogen-activated protein kinases ERK3 and ERK2 direct subcellular localization and upstream specificity in vivo.
Robinson MJ; Xu Be BE; Stippec S; Cobb MH
J Biol Chem; 2002 Feb; 277(7):5094-100. PubMed ID: 11741894
[TBL] [Abstract][Full Text] [Related]
9. Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5.
Déléris P; Rousseau J; Coulombe P; Rodier G; Tanguay PL; Meloche S
J Cell Physiol; 2008 Dec; 217(3):778-88. PubMed ID: 18720373
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
11. NPDC-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/proteasome system through a PEST degradation motif.
Spencer ML; Theodosiou M; Noonan DJ
J Biol Chem; 2004 Aug; 279(35):37069-78. PubMed ID: 15229225
[TBL] [Abstract][Full Text] [Related]
12. Proteasome- and p38-dependent regulation of ERK3 expression.
Zimmermann J; Lamerant N; Grossenbacher R; Furst P
J Biol Chem; 2001 Apr; 276(14):10759-66. PubMed ID: 11148204
[TBL] [Abstract][Full Text] [Related]
13. Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif.
Aberg E; Torgersen KM; Johansen B; Keyse SM; Perander M; Seternes OM
J Biol Chem; 2009 Jul; 284(29):19392-401. PubMed ID: 19473979
[TBL] [Abstract][Full Text] [Related]
14. ERK3-MK5 signaling regulates myogenic differentiation and muscle regeneration by promoting FoxO3 degradation.
Soulez M; Tanguay PL; Dô F; Dort J; Crist C; Kotlyarov A; Gaestel M; Ferron M; Dumont NA; Meloche S
J Cell Physiol; 2022 Apr; 237(4):2271-2287. PubMed ID: 35141958
[TBL] [Abstract][Full Text] [Related]
15. Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2.
Perander M; Al-Mahdi R; Jensen TC; Nunn JA; Kildalsen H; Johansen B; Gabrielsen M; Keyse SM; Seternes OM
Sci Rep; 2017 Mar; 7():43471. PubMed ID: 28252035
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism for mitogen-activated protein kinase localization.
Bind E; Kleyner Y; Skowronska-Krawczyk D; Bien E; Dynlacht BD; Sánchez I
Mol Biol Cell; 2004 Oct; 15(10):4457-66. PubMed ID: 15269285
[TBL] [Abstract][Full Text] [Related]
17. FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells.
An HJ; Lee CJ; Lee GE; Choi Y; Jeung D; Chen W; Lee HS; Kang HC; Lee JY; Kim DJ; Choi JS; Cho ES; Choi JS; Cho YY
Exp Mol Med; 2022 Jan; 54(1):35-46. PubMed ID: 35022544
[TBL] [Abstract][Full Text] [Related]
18. Reevaluation of the Role of Extracellular Signal-Regulated Kinase 3 in Perinatal Survival and Postnatal Growth Using New Genetically Engineered Mouse Models.
Soulez M; Saba-El-Leil MK; Turgeon B; Mathien S; Coulombe P; Klinger S; Rousseau J; Lévesque K; Meloche S
Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30642949
[TBL] [Abstract][Full Text] [Related]
19. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells.
Delmas C; Manenti S; Boudjelal A; Peyssonnaux C; Eychène A; Darbon JM
J Biol Chem; 2001 Sep; 276(37):34958-65. PubMed ID: 11418594
[TBL] [Abstract][Full Text] [Related]
20. ERK7 expression and kinase activity is regulated by the ubiquitin-proteosome pathway.
Kuo WL; Duke CJ; Abe MK; Kaplan EL; Gomes S; Rosner MR
J Biol Chem; 2004 May; 279(22):23073-81. PubMed ID: 15033983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
